Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations
NCT03381781
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
P53 Mutation
Interventions
DRUG:
Decitabine
DRUG:
Arsenic Trioxide
DRUG:
Cytarabine
Sponsor
Li Junmin